Patent briefs: Yaz patent invalid; FDA bars generic OxyContin; Appeals court backs GSK over Arzerra
17 April 2013
New rules in Canada to address Rx drug abuse
21 November 2012
Stock Commentary - New York week to April 20, 2009
23 April 2009
Teen OTC drug abuse falls, Rx level steady
22 December 2008
TheraQuest's TQ-1019 shows sustained efficacy in animals
1 September 2008
DEA block to US e-Rx adoption set to end
30 June 2008
Rx drug abuse kills three times more than cocaine
30 June 2008
J&J's tapentadol improves GI tolerability
23 June 2008
Shionogi's Crestor boosts fiscal 2007
2 June 2008
Illegal California pharmacy faces charges
2 June 2008
Watson's 1st-qtr 2008 net income jumps 60%
12 May 2008
Ph III Acurox trial enrolled
5 May 2008
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
Acura receives $30M from King Pharma deal
24 December 2007
US FDA clears Watson's generic Combunox
3 December 2007
Watson's 3rd-qtr 2007 revenue hits $594.7M
19 November 2007
$5M settlement over "improper" OxyContin marketing
1 October 2007
US state expands Rx drug database
13 August 2007
Crestor boosts Shionogi 1st-qtr fiscal sales 8.7%
6 August 2007
Tapentadol ER cuts pain intensity vs placebo
2 July 2007
Purdue pleads guilty to OxyContin charge
21 May 2007
Watson sees a 4th-qtr 2006 net loss of $489M
12 March 2007
Japan stock market week to Feb 19, 2007
26 February 2007
Shionogi launches Mundipharma's OxiNorm in Japan
12 February 2007
Teva drops challenge to OxyContin patent
6 November 2006
Japan stock market week to Oct 23, 2006
30 October 2006
Teva and Purdue agree OxyContin litigation settlement
4 September 2006
Shionogi's 2005 sales 196.4B yen, down 1.5%
29 May 2006
Legal uncertainty slows adoption of pharma RFID tracking
20 February 2006
FDA accepts Elite's OxyQD IND
6 February 2006
Rx use remains high among US teens: study
16 January 2006
Shionogi's fiscal half-year revenue up 1.6%
12 December 2005
Good 1st-qtr results for Shionogi
22 August 2005
IVAX to distribute generic OxyContin
20 June 2005
Forest Labs debuts Combunox in USA
28 March 2005
IMPAX launches generic OxyContin
14 March 2005
Elite sees promising results for its abuse-resistant technology
17 January 2005
Shionogi's full-year income plunges 62.7%
14 June 2004
Teva commercializing generic oxycodone 80mg in USA
5 April 2004
Endo net sales surge 49% in 2003
23 February 2004
Shionogi sales in line with forecasts
16 February 2004
Tokyo pharma stocks - week to July 14
21 July 2003
11 new drugs added to Japan's NHI price list
9 June 2003
IMPAX files generic Oxycontin XR 80mg in USA
4 March 2002
Florida sees Rx drug abuse deaths rocket
23 November 2001
PhRMA, others act as Rx drug abuse grows
12 April 2001
Purdue Pharma to merge with CoCensys
12 August 1999
Chirocaine approved in second market, the USA
10 August 1999
Showing 1-61 of 61 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
